China Medicine Profit Margin

China Medicine (CHME) currently reports a profit margin of 18.18% as of June 2026. That compares with 4.55% in the prior-year period — up 299.8% year over year. That is above the sector sector average of 13.4%. Use the charts on this page to explore China Medicine's profit margin history and peer comparisons.

China Medicine's profit margin increased from 4.55% to 18.18% — a 299.8% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

China Medicine's profit margin of 18.18% is higher than the its sector sector average of 13.4%. That is roughly 35.6% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but China Medicine's current 18.18% should be judged against industry norms (sector average: 13.4%) and against CHME's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 18.18%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.4%. From there, open related valuation or income-statement pages for China Medicine, and consider following CHME for alerts when major investors trade the stock.